St. Louis Suboxone Doctors

Dr. M.F. Ghani

M.F. Ghani, M.D.
6651 Chippewa Street, Suite #203
St. Louis, MO 63109

Phone: (314) 644-5300

Don’t let your dependence on opioids/pain killers control your life. We offer a compassionate, intensive and confidential Suboxone treatment to help you regain control and happiness in your life. Please call (314) 644-5300 to make an appointment today because you deserve special care.

Please call (314) 644-5300 to make an appointment

M.F. Ghani, M.D. – St. Louis, MO 63109

 

Join Here To Have Your Medical Practice Featured in this space

Following payment completion, please send us the listing information you would like displayed here.

methadone8c

St. Louis offers a useful list of doctors approved to prescribe suboxone to patients coping with opioid withdrawal. Addiction to opioids results in a range of uncomfortable withdrawal symptoms (body ache, diarrhea, nausea, vomiting, insomnia, and more) which yield severe physical and mental stress and can lead to mood disorder and decreased ability to meet one’s daily responsibilities. Buprenorphine is the element in Suboxone that eliminates opioid withdrawal. Suboxone has arrived as a popular and effective opioid replacement medication that returns an individual’s functioning after a period of decline in active opioid addiction. Only approved physicians are legally able to write prescriptions for buprenorphine/suboxone. If you are a local physician aiming to treat St. Louis area residents, you may purchase a featured listing at the top of this page insuring that your medical services will be found by prospective patients searching our website for quality opioid treatment.



St. Louis Buprenorphine Suboxone Doctors
M. F. Ghani, M.D. 6651 Chippewa St., Suite 203
St. Louis, MO 63109
(314) 644-5300
Midwest Health Center – St. Louis
Dr. David Greengart MD
8630 Delmar Blvd,
Suite #230
St. Louis MO, 63124
(314) 472-5016
John Deno Rogakos, M.D. 665 South Skinker Boulevard
Suite 110
St. Louis, MO 63108
(314) 725-2199
Latanya C. Tunstall-Robinson, M.D. 625 North Euclid
Suite 214
St. Louis, MO 63108
(314) 361-0477
Gurpreet S. Padda, M.D. 5203 Chippewa
Suite 301
St. Louis, MO 63109
(314) 481-5000
Celso Rodrigues, M.D. Arca
6651 Chipewa, Suite 224
St. Louis, MO 63109
(314) 645-6840
Donald David Bohnenkamp, M.D. 660 South Euclid Avenue
Campus Box 8134
St. Louis, MO 63110
(314) 286-1700
Dragan Svrakic, M.D. 660 South Euclid Avenue
Campus Box 8134
St. Louis, MO 63110
(314) 362-3903
Celeste Herleth, M.D. 1129 Macklind Avenue
St. Louis, MO 63110
(314) 534-0200
Brent R. Palmer, M.D. Bridgeway Behavioral Health
1027 South Vandeventer
St. Louis, MO 63110
(636) 224-1700
Richard John Leahy, D.O. 5624-A South Compton Street
St. Louis, MO 63111
(412) 434-6700
David Michael Glick Family Care Health Centers
401 Holly Hills
St. Louis, MO 63111
(314) 353-5190
Jack Eldon Simons, D.O. 9733 St. Charles Rock Road
St. Louis, MO 63114
(314) 423-7030
Junaid M. Syed, M.D. 3535 South Jefferson
Suite 104
St. Louis, MO 63118
(314) 776-7990
Jordan M. Balter, D.O. 6220 S. Lindbergh Blvd
Suite 203
St. Louis, MO 63123
(314) 845-0571
John Stanley Rabun, M.D. 9890 Clayton Road
Suite 100
St. Louis, MO 63124
(314) 725-1515
Ahmad B. Ardekani, M.D. 10004 Kennerly Road
Suite 310A
St. Louis, MO 63128
(314) 843-3310
Ashok Yanamadala, M.D 5000 Cedar Plaza Parkway
Suite 350
St. Louis, MO 63128
(314) 843-4333
Azfar Malik, M.D. 5000 Cedar Plaza
Suite 350
St. Louis, MO 63128
(314) 843-4333×2
Narendir T. Soorya, M.D. 5000 Cedar Plaza Parkway
Suite 350
St. Louis, MO 63128
(314) 843-4333×2
Gautam Datta, M.D. 5000 Cedar Plaza Parkway
Suite 350
St. Louis, MO 63128
(314) 843-4333
Shazia Malik, M.D. 5000 Cedar Plaza Parkway
Suite 350
St. Louis, MO 63128
(314) 843-4333
Mohinder Partap, M.D. 5000 Cedar Plaza Parkway
Suite 350
St. Louis, MO 63128
(314) 843-4333
Vivek Agnihotri, M.D. 745 Old Frontenac Square
Suite 201
St. Louis, MO 63131
(314) 395-8940
Vadim Y. Baram, M.D. 10199 Woodfield Lane
St. Louis, MO 63132
(314) 504-4698
Christine Joan Salter, M.D. 777 South New Ballas Road
Suite 230W
St. Louis, MO 63141
(314) 395-9777
Edwin D. Dunteman, M.D. 555 North New Ballas
Suite 165
St. Louis, MO 63141
(314) 692-7246
Fazle M. Yasin, M.D. 763 South New Ballas Road
Suite 110
St. Louis, MO 63141
(314) 843-4333×2
Stephen C. Stromsdorfer, M.D. 1066 Executive Parkway
Suite 110
St. Louis, MO 63141
(314) 205-1707
Gautam Datta, M.D. Psych Care Consultants
763 South New Ballas Road, Suite 110
St. Louis, MO 63141
(314) 569-1717
Jo-Ellyn M. Ryall, M.D. 763 South New Ballas Road
Suite 110
St. Louis, MO 63141
(314) 569-1717
Azfar Malik, M.D. 763 South New Ballas Road
Suite 110
St. Louis, MO 63141
(314) 843-4333×2


Treating Opioid Addiction

The science of treating opioid addiction has become increasingly popular in both medical circles and in the addiction treatment community.

For decades, medical professionals and even popular recovery organizations did not quite understand how giving an opioid addict a replacement medication could actually facilitate recovery.

Part of the dilemma was that those who defined “recovery” did so using an old school philosophical approach originally crafted for alcoholism. But science has taught us that not all addictions are exactly the same. While there are certainly commonalities between the various substance use disorders, there are very important distinctions and differences which affect the recovery process.

You cannot prescribe a medication that is effective with depression, and expect that same medication to resolve schizophrenia or an anxiety disorder. While they are all mental health disorders that can debilitate a patient, there are critical differences between these disorders and in the overall treatment plan for addressing each one.

Similarly with addiction, science is teaching us that a one-size-fits-all approach to addiction recovery is detrimental and often unproductive.

With opioid addiction in particular, the disease progression is quite unlike most other addictive illnesses. While the medical profession has evolved that understanding, the recovery community and general society has at times struggled to comprehend the necessity of medication-assisted treatment for the opioid addicted.

Physicians, Nurse Practitioners, PA’s, Nurses, and Counselors all play a part in educating patients, their families, the community, and government on the key role that medication plays in the successful management of an opioid use disorder. Methadone, subutex, suboxone, vivitrol, and other medication choices make the difference between recovery success and repeated recovery failures.

Posted in Addiction Treatment, Buprenorphine, Methadone, Methadone Clinics, Methadone Maintenance, Suboxone, Suboxone Doctors, Subutex, Vivitrol | Tagged , , | Comments Off on Treating Opioid Addiction

Overdose Fatalities Beginning to Decrease

Various news outlets are reporting new statistics which indicate deaths from opioid overdose are beginning to go down.

The Associated Press reports that for the first time in a decade overdoses among New York residents (outside of NYC) have declined 15.9%. Government officials are quoted as saying that about 80% of the overdose deaths were attributable to heroin or fentanyl.

The AP cited a new CDC (Centers For Disease Control) July 2019 study which showed overdose deaths in 2018 fell for the first time in nearly three decades.

Various public education efforts and New York’s Opioid Task Force are thought to be significant catalysts for the slowdown in opioid overdoses. The availability of naloxone has also been highly instrumental in impacting overdoses nationwide with many communities across the country now providing naloxone kits for free.

A number of metro areas in the U.S. are also examining the feasibility of mobile opioid treatment since transportation to clinics or physicians is often an impediment to accessing medication-assisted treatment resources.

Posted in Addiction Counseling, Heroin Overdose, Medication Assisted Treatment, Methadone, Methadone Clinics, Naloxone, Suboxone, Suboxone Doctors | Tagged , | Comments Off on Overdose Fatalities Beginning to Decrease

Comprehensive Opioid Treatment at Behavioral Health Group

Behavioral Health Group (BHG) currently provides 58 top flight opioid addiction treatment centers in the United States. The company specializes in medication-assisted treatment using methadone, buprenorphine, and buprenorphine/naloxone.

BHG takes a patient-centered approach to treating addictive disorders offering counseling as a fundamental component of the overall treatment model. Because of this individualized treatment approach, 97% of patients surveyed indicate they would recommend BHG Recovery to a friend or family member suffering from opioid addiction.

Additionally, 99% of patients report that their mental health and quality of life improved since their BHG admission. 60% of unemployed patients were able to obtain employment after one year of treatment.

Hope, Respect, and Caring are tenets of BHG’s treatment program, and their staff strive to provide this from the moment a patient first walks in to receive help. All of BHG’s treatment centers provide care in an outpatient setting.

In 2019 and 2020, BHG Recovery added (10) additional U.S. clinics to the Methadone.US national directory list …

1. Franklin, VA – BHG Franklin Treatment Center
2. Chesapeake, VA – BHG Chesapeake South Treatment Center
3. Glen Allen, VA – BHG Glen Allen Treatment Center
4. Mobile, AL – BHG Mobile Treatment Center
5. Cullman, AL – BHG Cullman Treatment Center
6. Washington, DC – BHG Washington DC Treatment Center
7. Colorado Springs, CO – BHG Colorado Springs Treatment Center
8. Grand Bay, AL – BHG Grand Bay Treatment Center
9. North Little Rock, AR – BHG North Little Rock Treatment Center
10. Savannah, TN – BHG Savannah Treatment Center

Posted in BHG Recovery, Buprenorphine, Medication Assisted Treatment, Methadone, Methadone Clinics, Opioid Treatment, Suboxone, Suboxone Doctors | Tagged | Comments Off on Comprehensive Opioid Treatment at Behavioral Health Group

Subutex and Methadone in Treatment of Opioid Addiction

Recovery from opioid addiction initially centers around physical stabilization: specifically the management of opioid withdrawal. This is an essential step for the vast majority of opioid addicted people seeking help. Research has shown a 90% failure rate for opioid treatment programs that do not offer medication assistance.

Methadone was the original medication FDA-approved for treating opioid addiction although Subutex has been recently introduced into opioid treatment programs around the country as a viable alternative. Subutex is effective especially for milder levels of opioid dependency.

Subutex is a brand name version of buprenorphine, the partial opioid agonist that reduces withdrawal symptom sickness. Most patients are familiar with “Suboxone” which is a popular buprenorphine-based film that is dissolved under the tongue and is taken once per day. It differs from Subutex in that it contains naloxone so that it cannot be easily abused intravenously.

A number of methadone clinics began offering subutex in the past few years in an effort to expand treatment options for patients. Because subutex can be abused, it is typically administered daily in the clinic by a nurse where it can be supervised.

If you are considering entering a treatment program for opioid misuse, you may want to ask about the variety of medications utilized by the clinic or physician. Some patients have successfully transitioned from methadone to subutex while others enter the program starting with subutex. This is a decision best made in conjunction with your treating doctor who can formulate a treatment plan based on your history of opioid use.

Posted in Addiction Recovery, Buprenorphine, Medication Assisted Treatment, Methadone, Methadone Clinics, Suboxone, Subutex | Tagged | Comments Off on Subutex and Methadone in Treatment of Opioid Addiction